Retinopathy of prematurity

A Hellström, LEH Smith, O Dammann - The lancet, 2013 - thelancet.com
The immature retinas of preterm neonates are susceptible to insults that disrupt
neurovascular growth, leading to retinopathy of prematurity. Suppression of growth factors …

[HTML][HTML] Retinopathy of prematurity: Past, present and future

PK Shah, V Prabhu, SS Karandikar… - World journal of …, 2016 - ncbi.nlm.nih.gov
Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the retina occurring
principally in new born preterm infants. It is an avoidable cause of childhood blindness. With …

Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective

T Chan-Ling, GA Gole, GE Quinn, SJ Adamson… - Progress in retinal and …, 2018 - Elsevier
The population of infants at risk for retinopathy of prematurity (ROP) varies by world region;
in countries with well developed neonatal intensive care services, the highest risk infants are …

The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge

G Cavallaro, L Filippi, P Bagnoli… - Acta …, 2014 - Wiley Online Library
Retinopathy of prematurity (ROP) is a disease that can cause blindness in very low
birthweight infants. The incidence of ROP is closely correlated with the weight and the …

[HTML][HTML] Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options

FM Mutlu, SU Sarici - International Journal of Ophthalmology, 2013 - ncbi.nlm.nih.gov
Retinopathy of prematurity (ROP), a retinal vascular disease of premature infants, continues
to be a major cause of preventable childhood blindness all over the world. The incidence of …

Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives

L Filippi, G Cavallaro, P Bagnoli, M Dal Monte… - The Journal of …, 2013 - Elsevier
Objective To evaluate safety and efficacy of oral propranolol administration in preterm
newborns affected by an early phase of retinopathy of prematurity (ROP). Study design Fifty …

Decoupling oxygen tension from retinal vascularization as a new perspective for management of retinopathy of prematurity. New opportunities from β-adrenoceptors

L Filippi, M Cammalleri, R Amato, M Ciantelli… - Frontiers in …, 2022 - frontiersin.org
Retinopathy of prematurity (ROP) is an evolutive and potentially blinding eye disease that
affects preterm newborns. Unfortunately, until now no conservative therapy of active ROP …

Effectiveness of propranolol in preventing severe retinopathy of prematurity: a comprehensive systematic review and meta-analysis

MA Shafique, A Haseeb, MMN Uddin, B Asghar… - American Journal of …, 2024 - Elsevier
PURPOSE To learn more about the effectiveness of oral propranolol as a therapeutic
alternative for preterm newborns with pre-existing retinopathy of prematurity (ROP) as well …

Antiangiogenic effects of β2‐adrenergic receptor blockade in a mouse model of oxygen‐induced retinopathy

D Martini, MD Monte, C Ristori, E Cupisti… - Journal of …, 2011 - Wiley Online Library
J. Neurochem.(2011) 10.1111/j. 1471‐4159.2011. 07530. x Abstract Oxygen‐induced
retinopathy (OIR) is a model for human retinopathy of prematurity. In mice with OIR, beta …

The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases

G Casini, M Dal Monte, I Fornaciari, L Filippi… - Progress in Retinal and …, 2014 - Elsevier
Retinal neovascular pathologies, such as diabetic retinopathy, retinopathy of prematurity
(ROP) and age-related macular degeneration, may be treated with intravitreal injections of …